Sumitomo Mitsui Trust Holdings, Inc. Beam Therapeutics Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

$142 Billion
Q3 2024

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 3,552,829 shares of BEAM stock, worth $89.8 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,552,829

Previous 2,224,415 59.72%

Holding current value

$89.8 Million

Previous $52.1 Million 67.01%

% of portfolio

0.06%

Previous 0.04%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$22.57 - $33.14 $30 Million - $44 Million	1,328,414 Added 59.72%	3,552,829 $87 Million
Q2 2024 Jul 19, 2024	SELL	$21.22 - $32.66 $2.92 Million - $4.49 Million	-137,402 Reduced 5.82%	2,224,415 $52.1 Million
Q1 2024 Apr 19, 2024	BUY	$23.46 - $45.07 $87,411 - $167,930	3,726 Added 0.16%	2,361,817 $78 Million
Q4 2023 Jan 30, 2024	BUY	$17.69 - $30.76 $12.7 Million - $22 Million	715,911 Added 43.6%	2,358,091 $64.2 Million
Q3 2023 Oct 30, 2023	BUY	$23.01 - $32.46 $9.83 Million - $13.9 Million	427,100 Added 35.15%	1,642,180 $39.5 Million
Q2 2023 Jul 31, 2023	BUY	$29.32 - $35.99 $16.3 Million - $20 Million	556,514 Added 84.5%	1,215,080 $38.8 Million
Q1 2023 Apr 27, 2023	SELL	$30.15 - $48.79 $455,988 - $737,899	-15,124 Reduced 2.24%	658,566 $20.2 Million
Q4 2022 Jan 30, 2023	BUY	$36.73 - $51.6 $5.98 Million - $8.4 Million	162,759 Added 31.86%	673,690 $26.3 Million
Q3 2022 Oct 21, 2022	BUY	$39.79 - $70.31 $8.71 Million - $15.4 Million	218,969 Added 75.0%	510,931 $24.3 Million
Q2 2022 Jul 26, 2022	BUY	$29.86 - $62.36 $252,406 - $527,129	8,453 Added 2.98%	291,962 $11.3 Million
Q1 2022 Apr 27, 2022	BUY	$53.73 - $82.16 $3.13 Million - $4.79 Million	58,286 Added 25.88%	283,509 $16.2 Million
Q4 2021 Feb 02, 2022	SELL	$68.02 - $99.06 $1.98 Million - $2.89 Million	-29,132 Reduced 11.45%	225,223 $17.9 Million
Q3 2021 Oct 25, 2021	SELL	$84.37 - $133.6 $186,457 - $295,256	-2,210 Reduced 0.86%	254,355 $22.1 Million
Q2 2021 Aug 02, 2021	BUY	$64.12 - $128.71 $1.74 Million - $3.5 Million	27,164 Added 11.84%	256,565 $33 Million
Q1 2021 Apr 30, 2021	BUY	$71.28 - $120.75 $1.79 Million - $3.04 Million	25,159 Added 12.32%	229,401 $18.4 Million
Q4 2020 Feb 05, 2021	BUY	$22.24 - $95.63 $4.54 Million - $19.5 Million	204,242 New	204,242 $16.7 Million

Others Institutions Holding BEAM

# of Institutions

236

Shares Held

75.2M

Call Options Held

438K

Put Options Held

232K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Account

Sumitomo Mitsui Trust Holdings, Inc. Beam Therapeutics Inc. Transaction History